Beth Israel Deaconess Medical Center — Boston, Massachusetts

Public research footprint of Beth Israel Deaconess Medical Center, compiled from the ClinicalTrials.gov public registry.

2,295

Registered studies

614

Active

296

Recruiting now

1,282

Completed

321

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia Arising From Previous… · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Stage IV Cutaneous Melanoma AJCC v6 and v7 · Myelodysplastic Syndrome

Recently updated registry entries

NCT02196181 — Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer… (Active Not Recruiting)
NCT05600894 — Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic… (Active Not Recruiting)
NCT05702034 — A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Beth Israel Deaconess Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.